



changes during the 20th century
have affected the health of
women. Many of the changes
have benefited women’s health,
but some have had deleterious
effects. Infectious diseases pose
an especially formidable threat
to women, claiming >15 mil-
lion lives around the globe each
year (1). For many infectious
diseases, women are at higher risk and have a more severe
course of illness than men for many reasons, including bio-
logic differences, social inequities, and restrictive cultural
norms. These are often the same factors responsible for the
disproportionate disease incidence among vulnerable pop-
ulations throughout the world. Efforts to recognize and
reduce health disparities among women have particular
relevance for global health.
HIV and AIDS in Women
In addition to hunger, lack of education, and environ-
mental and sociocultural constraints, HIV/AIDS and
malaria, along with tuberculosis, continue to dispropor-
tionately affect and further weaken the condition of
women in many of the world’s poorest regions. Recent
estimates indicate that more than half of the estimated 38
million cases of adult HIV infection worldwide are in
women (2). Moreover, the social, economic, and psycho-
logic effects of the disease are more severe for women.
When their partners or fathers die, women often lose eco-
nomic rights. A Ugandan survey found that one in four
widows reported losing their property after their partner
died (3). 
In sub-Saharan Africa, the region most affected by HIV,
women are 30% more likely than men to be HIV-infected
(2). The largest gender difference occurs among younger
age groups. New HIV infections among women are also on
the rise in the United States. An analysis of newly diag-
nosed HIV infections that occurred in 29 states from 1999
to 2002 showed that more than one third (35%) of cases
resulted from heterosexual contact; among these hetero-
sexually transmitted infections, almost two thirds (64%)
occurred in women (4). Similarly, a recent analysis of New
York City’s HIV reporting data found that 35% of new
HIV diagnoses in 2001 were in women, compared with
28% before 2001 (5).
HIV infection in women has obvious implications for
the health and well-being of children. HIV infection can
be transmitted perinatally, and increasing numbers of chil-
dren—estimated at ≈12 million—are orphaned by the dis-
ease (2). Although preventing HIV transmission from an
infected mother to her infant has become feasible because
of effective antiretroviral treatment regimens and has met
with great success in many parts of the world, services
that prevent mother-to-child transmission are severely
limited in low-income countries.  Similarly, although
combination antiretroviral therapy offers the potential to
manage the disease as a chronic, treatable condition,
access to such treatment is primarily limited to persons in
high-income countries, which excludes the most severely
affected regions. As an example, ≈4.1 million persons in
Africa are in need of such therapy, but <2% have access to
the drugs (6).
Preventing new infections is fundamental to stopping
the spread of HIV. Attaining this goal requires that all per-
sons have information about the disease and know their
infection status, a formidable challenge in both low- and
high-income countries. Such information can help
uninfected persons remain free of the disease and help
those who are infected gain access to treatment and pre-
vent transmission to their partners. Fortunately, several
broad-based national and international initiatives have
been taken to meet these challenges. For example, the
President’s Emergency Plan for AIDS Relief is a 5-year,
$15 billion commitment to treat HIV infection and prevent
new infections in Africa and the Caribbean. Other under-
takings include the United Nations’ Global Fund to Fight
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AIDS, Tuberculosis, and Malaria and “The 3 by 5
Initiative,” a detailed, multicountry plan developed by the
World Health Organization and the Joint United Nations
Programme on HIV/AIDS to provide antiretroviral treat-
ment to 3 million HIV-infected persons in developing
countries by the end of 2005.
Malaria in Women
Malaria is another infectious disease threat that dispro-
portionately affects women; it causes serious illness in
pregnant women and children <5 years of age. Every year,
malaria kills 1.5 million to 2.7 million persons and
adversely affects another 300,000 to 500,000, mostly in
Africa (7,8). Pregnant women suffer decreased immunity
to malaria, which more than doubles their chances of con-
tracting and dying of the disease (9). Pregnant women who
contract malaria have an increased risk for severe maternal
anemia. The consequent impaired fetal growth contributes
to low birthweight in newborns. Malaria during pregnancy
causes as many as 10,000 maternal deaths each year,
8%–14% of all low birthweight babies, and 3%–8% of all
infant deaths in certain parts of Africa (9).  
Other Infectious Diseases in Women
In addition to HIV, women are more susceptible to
other sexually transmitted diseases (STDs) and their long-
term complications. In the United States >50% of prevent-
able infertility is related to STDs (10). In addition, most
sexually transmitted pathogens can be passed to the fetus
or infant, sometimes with fatal consequences. 
Longitudinal studies show that women are also at
greater risk for active disease from Mycobacterium tuber-
culosis infection (11). Case-fatality rates are likewise high-
er in women. Reasons include decreased immune function
attributed to poor nutritional status and delays in seeking
care, both of which can be a function of gender. 
The tropical parasitic disease schistosomiasis presents
special concerns for women. Among parasitic diseases,
schistosomiasis is second to malaria in prevalence; it
affects >200 million persons in 74 countries (12). In affect-
ed areas, women are at greater risk for the disease than
men because of their increased exposure to contaminated
water through domestic work, such as washing clothes and
preparing food. Consequences of the disease are more
severe in women than in men. Female genital schistosomi-
asis, often misdiagnosed as an STD, can cause tumors,
ulcers, and infertility and may actually increase the risk for
STDs (13).
Infectious Diseases in Pregnant Women
Pregnancy complicates the impact of many other infec-
tious diseases. Each year in the United States, ≈20,000
infants are born to women infected with hepatitis B virus
(HBV) (14). Without postexposure prophylaxis, ≈6,000 of
these infants would become chronically infected with
HBV, and ≈1,500 would die prematurely of chronic liver
disease. To address this problem, perinatal HBV preven-
tion programs screen pregnant women for HBV and fol-
low-up with vaccination of newborns. Hepatitis C virus
can also be transmitted during pregnancy, although the rate
of infection appears lower than that of HBV. Hepatitis E
virus can also have severe consequences if acquired during
pregnancy, especially during the third trimester (15,16).
This virus has been associated with increased risk for
spontaneous abortions and stillbirths as well as fulminant
hepatitis in both mothers and infants (16).  
Another serious maternal infection is group B strepto-
coccus (GBS). GBS can be transmitted from mother to
baby during pregnancy or during labor and delivery.
During the 1990s, prevention efforts involving intrapartum
antibiotic prophylaxis dramatically lowered the incidence
of disease (17). However, GBS remains a leading infec-
tious cause of illness and death among newborns in the
United States (18,19). 
Reducing Health Disparities in Women
Women are caretakers and brokers of health for their
families. These roles can increase their risk for infectious
diseases and increase obstacles to adequate and timely
treatment. Seeking health care can be the first step to iden-
tifying and treating a host of illnesses affecting women and
their families. Therefore, innovative ways to reach women
at risk, including developing new research agendas to
identify and address gender differences in infectious dis-
ease, are especially needed. 
Reducing health disparities for women requires a multi-
disciplinary global effort to combat the root causes of these
disparities—social, economic, and educational inequities
that fuel the spread of diseases and perpetuate poverty
throughout the world. Although much remains to be done,
commitment to reduce these disparities on behalf of the
international community is increasing. In addition, partici-
pants at the International Conference on Women and
Infectious Diseases also play an important role in these
efforts through their broad range of expertise and commit-
ment to improving global health. 
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